Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Bayer AG buy MutualVenture52

Start price
€19.30
02.12.24 / 50%
Target price
-
02.01.25
Performance (%)
0.45%
End price
€19.39
03.01.25
Summary
This prediction ended on 03.01.25 with a price of €19.39. The BUY prediction by MutualVenture52 for Bayer AG closed nearly unchanged. MutualVenture52 has 50% into this prediction

Bayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.

Performance without dividends (%)
Name 1w 1m 1y
Bayer AG -4.544% -4.544% 82.234%
iShares Core DAX® -1.212% 1.925% 17.589%
iShares Nasdaq 100 -4.714% -1.810% 0.450%
iShares Nikkei 225® -2.976% -2.660% 10.156%
iShares S&P 500 -2.744% -0.448% 0.320%

Comments by MutualVenture52 for this prediction

In the thread Trading Bayer AG
Prediction Buy
Perf. (%) 0.45%
Target price
Change
Ends at 02.01.25

Die von MutualVenture52 gewählte maximale Laufzeit wurde überschritten